Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -4.5 Million USD | 66.21% |
| 2023 | -13.32 Million USD | 18.47% |
| 2022 | -16.34 Million USD | -66.44% |
| 2021 | -9.81 Million USD | -3.75% |
| 2020 | -9.46 Million USD | -230.23% |
| 2019 | -2.86 Million USD | 53.27% |
| 2018 | -6.13 Million USD | -489.42% |
| 2017 | -1.04 Million USD | 34.8% |
| 2016 | -1.59 Million USD | -127.87% |
| 2015 | -700.36 Thousand USD | -154.55% |
| 2014 | 1.28 Million USD | -49.92% |
| 2013 | 2.56 Million USD | -27.09% |
| 2012 | 3.51 Million USD | 49.24% |
| 2011 | 2.35 Million USD | 27.08% |
| 2010 | 1.85 Million USD | -21.64% |
| 2009 | 2.36 Million USD | 345.21% |
| 2008 | 531.45 Thousand USD | 372.85% |
| 2007 | 112.39 Thousand USD | 167.5% |
| 2006 | -166.51 Thousand USD | -134.43% |
| 2005 | 483.68 Thousand USD | -28.17% |
| 2004 | 673.38 Thousand USD | -36.24% |
| 2003 | 1.05 Million USD | 13.95% |
| 2002 | 926.83 Thousand USD | -45.49% |
| 2001 | 1.7 Million USD | 449.02% |
| 2000 | 309.69 Thousand USD | 10247.15% |
| 1999 | -3052.00 USD | -381.39% |
| 1998 | -634.00 USD | 74.48% |
| 1997 | -2484.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -9.09 Million USD | 22.59% |
| 2024 Q4 | -4.5 Million USD | 35.34% |
| 2024 Q3 | -6.96 Million USD | 23.47% |
| 2024 FY | -4.5 Million USD | 66.21% |
| 2024 Q1 | -11.75 Million USD | 11.79% |
| 2023 Q2 | -18.27 Million USD | -28.57% |
| 2023 Q3 | -16.22 Million USD | 11.23% |
| 2023 FY | -13.32 Million USD | 18.47% |
| 2023 Q1 | -14.21 Million USD | 13.0% |
| 2023 Q4 | -13.32 Million USD | 17.89% |
| 2022 Q2 | -23.22 Million USD | 7.67% |
| 2022 Q1 | -25.15 Million USD | -156.18% |
| 2022 FY | -16.34 Million USD | -66.44% |
| 2022 Q4 | -16.34 Million USD | 18.5% |
| 2022 Q3 | -20.05 Million USD | 13.65% |
| 2021 Q2 | -14.38 Million USD | 7.84% |
| 2021 Q3 | -12.06 Million USD | 16.11% |
| 2021 Q4 | -9.81 Million USD | 18.61% |
| 2021 FY | -9.81 Million USD | -3.75% |
| 2021 Q1 | -15.6 Million USD | -64.89% |
| 2020 Q3 | -3.89 Million USD | -551.02% |
| 2020 Q4 | -9.46 Million USD | -143.02% |
| 2020 FY | -9.46 Million USD | -230.23% |
| 2020 Q1 | -1.38 Million USD | 51.52% |
| 2020 Q2 | -598.17 Thousand USD | 56.95% |
| 2019 FY | -2.86 Million USD | 53.27% |
| 2019 Q4 | -2.86 Million USD | 26.38% |
| 2019 Q1 | -5.25 Million USD | 14.37% |
| 2019 Q2 | -4.17 Million USD | 20.46% |
| 2019 Q3 | -3.89 Million USD | 6.8% |
| 2018 Q2 | -139.49 Thousand USD | -119.27% |
| 2018 Q4 | -6.13 Million USD | -27.77% |
| 2018 FY | -6.13 Million USD | -489.42% |
| 2018 Q1 | 723.7 Thousand USD | 169.55% |
| 2018 Q3 | -4.79 Million USD | -3340.98% |
| 2017 Q2 | 49.46 Thousand USD | 107.3% |
| 2017 Q4 | -1.04 Million USD | -385.72% |
| 2017 FY | -1.04 Million USD | 34.8% |
| 2017 Q1 | -677.44 Thousand USD | 57.55% |
| 2017 Q3 | -214.21 Thousand USD | -533.09% |
| 2016 Q4 | -1.59 Million USD | 43.33% |
| 2016 FY | -1.59 Million USD | -127.87% |
| 2016 Q1 | -5.4 Million USD | -671.2% |
| 2016 Q2 | -3.86 Million USD | 28.39% |
| 2016 Q3 | -2.81 Million USD | 27.19% |
| 2015 Q3 | -2.48 Million USD | -318.76% |
| 2015 Q1 | 1.06 Million USD | -16.91% |
| 2015 FY | -700.36 Thousand USD | -154.55% |
| 2015 Q4 | -700.36 Thousand USD | 71.86% |
| 2015 Q2 | 1.13 Million USD | 6.65% |
| 2014 Q2 | 2.82 Million USD | 14.69% |
| 2014 Q1 | 2.46 Million USD | -3.9% |
| 2014 Q4 | 1.28 Million USD | 64.59% |
| 2014 FY | 1.28 Million USD | -49.92% |
| 2014 Q3 | 780 Thousand USD | -72.4% |
| 2013 Q3 | 2.65 Million USD | 3.28% |
| 2013 Q2 | 2.57 Million USD | -7.32% |
| 2013 Q1 | 2.77 Million USD | -21.07% |
| 2013 FY | 2.56 Million USD | -27.09% |
| 2013 Q4 | 2.56 Million USD | -3.51% |
| 2012 FY | 3.51 Million USD | 49.24% |
| 2012 Q1 | 2.53 Million USD | 7.5% |
| 2012 Q4 | 3.51 Million USD | 30.58% |
| 2012 Q2 | 2.88 Million USD | 13.87% |
| 2012 Q3 | 2.69 Million USD | -6.64% |
| 2011 Q1 | 1.99 Million USD | 7.81% |
| 2011 Q4 | 2.35 Million USD | 29.86% |
| 2011 Q3 | 1.81 Million USD | 12.89% |
| 2011 FY | 2.35 Million USD | 27.08% |
| 2011 Q2 | 1.6 Million USD | -19.6% |
| 2010 Q1 | 1.88 Million USD | -20.36% |
| 2010 FY | 1.85 Million USD | -21.64% |
| 2010 Q4 | 1.85 Million USD | 9.9% |
| 2010 Q3 | 1.68 Million USD | -2.73% |
| 2010 Q2 | 1.73 Million USD | -7.96% |
| 2009 Q4 | 2.36 Million USD | -11.5% |
| 2009 Q2 | 1.93 Million USD | 82.29% |
| 2009 FY | 2.36 Million USD | 345.21% |
| 2009 Q3 | 2.67 Million USD | 38.44% |
| 2009 Q1 | 1.05 Million USD | 99.35% |
| 2008 Q2 | 402.11 Thousand USD | -26.87% |
| 2008 Q4 | 531.45 Thousand USD | -46.04% |
| 2008 Q3 | 984.94 Thousand USD | 144.94% |
| 2008 FY | 531.45 Thousand USD | 372.85% |
| 2008 Q1 | 549.84 Thousand USD | 389.21% |
| 2007 Q1 | 288.76 Thousand USD | 273.42% |
| 2007 Q4 | 112.39 Thousand USD | -84.75% |
| 2007 Q3 | 737.2 Thousand USD | 2.83% |
| 2007 Q2 | 716.91 Thousand USD | 148.27% |
| 2007 FY | 112.39 Thousand USD | 167.5% |
| 2006 FY | -166.51 Thousand USD | -134.43% |
| 2006 Q1 | 582.89 Thousand USD | 20.51% |
| 2006 Q4 | -166.51 Thousand USD | -137.72% |
| 2006 Q2 | 596.26 Thousand USD | 2.3% |
| 2006 Q3 | 441.4 Thousand USD | -25.97% |
| 2005 Q3 | 432.08 Thousand USD | -8.66% |
| 2005 Q1 | 262.75 Thousand USD | -60.98% |
| 2005 FY | 483.68 Thousand USD | -28.17% |
| 2005 Q4 | 483.68 Thousand USD | 11.94% |
| 2005 Q2 | 473.07 Thousand USD | 80.05% |
| 2004 Q2 | 1.05 Million USD | 0.0% |
| 2004 FY | 673.38 Thousand USD | -36.24% |
| 2004 Q3 | 946.94 Thousand USD | -9.95% |
| 2004 Q4 | 673.38 Thousand USD | -28.89% |
| 2004 Q1 | 1.05 Million USD | -0.44% |
| 2003 Q3 | 1.15 Million USD | 5.66% |
| 2003 Q4 | 1.05 Million USD | -8.4% |
| 2003 Q2 | 1.09 Million USD | 19.01% |
| 2003 Q1 | 916.99 Thousand USD | -1.06% |
| 2003 FY | 1.05 Million USD | 13.95% |
| 2002 Q3 | 1.85 Million USD | 3.76% |
| 2002 Q1 | 1.59 Million USD | -6.28% |
| 2002 Q2 | 1.78 Million USD | 11.97% |
| 2002 FY | 926.83 Thousand USD | -45.49% |
| 2002 Q4 | 926.83 Thousand USD | -49.93% |
| 2001 FY | 1.7 Million USD | 449.02% |
| 2001 Q3 | 1.44 Million USD | 38.39% |
| 2001 Q4 | 1.7 Million USD | 17.93% |
| 2001 Q1 | 728 Thousand USD | 135.07% |
| 2001 Q2 | 1.04 Million USD | 43.1% |
| 2000 FY | 309.69 Thousand USD | 10247.15% |
| 2000 Q1 | 56.39 Thousand USD | 0.0% |
| 2000 Q2 | 183.11 Thousand USD | 224.74% |
| 2000 Q4 | 309.69 Thousand USD | -43.59% |
| 2000 Q3 | 549.03 Thousand USD | 199.83% |
| 1999 FY | -3052.00 USD | -381.39% |
| 1998 FY | -634.00 USD | 74.48% |
| 1997 FY | -2484.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 116.622% |
| BrainsWay Ltd. | -10.32 Million USD | 56.379% |
| Cerus Corporation | 84.35 Million USD | 105.337% |
| Envoy Medical, Inc. | -3.81 Million USD | -18.03% |
| electroCore, Inc. | -9.95 Million USD | 54.78% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 12.163% |
| IceCure Medical Ltd | -9.93 Million USD | 54.684% |
| Inogen, Inc. | -103.56 Million USD | 95.653% |
| OrthoPediatrics Corp. | -9.26 Million USD | 51.423% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -23.638% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 65.628% |
| MaxCyte, Inc. | -27.76 Million USD | 83.785% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 12.387% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -681.855% |
| Orthofix Medical Inc. | 96.44 Million USD | 104.668% |
| PAVmed Inc | 29.08 Million USD | 115.477% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 73.424% |
| RxSight, Inc. | -6.68 Million USD | 32.61% |
| Sight Sciences, Inc. | -102.71 Million USD | 95.617% |
| SI-BONE, Inc. | 5.72 Million USD | 178.687% |
| TELA Bio, Inc. | -3.94 Million USD | -13.995% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 107.853% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 1378.881% |
| Acutus Medical, Inc. | 12.27 Million USD | 136.661% |
| Talis Biomedical Corporation | -57.06 Million USD | 92.111% |
| Spectral AI, Inc. | -3.5 Million USD | -28.582% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 90.627% |
| CVRx, Inc. | -59.95 Million USD | 92.492% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 326.882% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 452.343% |
| Bioventus Inc. | 372.51 Million USD | 101.208% |
| Venus Concept Inc. | 74.3 Million USD | 106.059% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 55.788% |
| LivaNova PLC | 62.53 Million USD | 107.199% |
| 908 Devices Inc. | -115.09 Million USD | 96.089% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 101.404% |
| Nemaura Medical Inc. | 9.92 Million USD | 145.357% |
| NeuroPace, Inc. | 54.33 Million USD | 108.285% |
| LENSAR, Inc. | -18.31 Million USD | 75.417% |
| Apyx Medical Corporation | -5.15 Million USD | 12.606% |
| Cutera, Inc. | 288.3 Million USD | 101.561% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 159.902% |
| BioSig Technologies, Inc. | 262 Thousand USD | 1818.192% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 89.729% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 51.064% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.32% |
| Axonics, Inc. | -77.19 Million USD | 94.168% |
| Outset Medical, Inc. | 67.67 Million USD | 106.651% |
| IRIDEX Corporation | -4.28 Million USD | -4.983% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 97.471% |
| IRadimed Corporation | -47.71 Million USD | 90.566% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -48.766% |
| INVO Bioscience, Inc. | 8.45 Million USD | 153.267% |
| Telesis Bio, Inc. | 32.63 Million USD | 113.794% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -79.913% |
| Varex Imaging Corporation | 316.9 Million USD | 101.421% |
| Quipt Home Medical Corp. | 81.73 Million USD | 105.508% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -61.814% |
| Pulmonx Corporation | -42.36 Million USD | 89.373% |
| Dynatronics Corporation | 6.2 Million USD | 172.56% |
| Modular Medical, Inc. | -8.04 Million USD | 44.023% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -4.763% |
| Semler Scientific, Inc. | -57.13 Million USD | 92.12% |
| InMode Ltd. | -135.39 Million USD | 96.675% |
| Bruker Corporation | 891.3 Million USD | 100.505% |
| Cytosorbents Corporation | 4.18 Million USD | 207.643% |
| DexCom, Inc. | 2.02 Billion USD | 100.222% |
| Align Technology, Inc. | -840.47 Million USD | 99.464% |
| Viveve Medical, Inc. | -13.81 Million USD | 67.41% |
| ZimVie Inc. | 450.41 Million USD | 100.999% |
| Movano Inc. | -5.86 Million USD | 23.258% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 96.652% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -681.855% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 326.882% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 101.262% |
| Profound Medical Corp. | -18.17 Million USD | 75.236% |
| Insulet Corporation | 798.1 Million USD | 100.564% |
| enVVeno Medical Corporation | -2.21 Million USD | -102.96% |
| Surmodics, Inc. | -12.01 Million USD | 62.53% |
| iCAD, Inc. | -21.2 Million USD | 78.775% |
| Nuwellis, Inc. | -2.81 Million USD | -59.69% |
| Biotricity, Inc. | 23.09 Million USD | 119.494% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 104.807% |
| InspireMD, Inc. | -8.04 Million USD | 44.044% |
| PAVmed Inc. | 29.08 Million USD | 115.477% |
| BIOLASE, Inc. | 11.34 Million USD | 139.683% |
| Beyond Air, Inc. | 6.22 Million USD | 172.269% |
| FONAR Corporation | -14.66 Million USD | 69.304% |
| AxoGen, Inc. | 32.26 Million USD | 113.952% |
| Vivani Medical, Inc. | 42 Thousand USD | 10818.243% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 57.763% |
| Inari Medical, Inc. | -7.16 Million USD | 37.136% |
| UFP Technologies, Inc. | 40.77 Million USD | 111.041% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 246.7% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 5.651% |
| Tenon Medical, Inc. | -1.25 Million USD | -258.698% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 40.814% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 62.254% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.203% |
| Sintx Technologies, Inc. | 905 Thousand USD | 597.421% |
| NanoVibronix, Inc. | -3.27 Million USD | -37.33% |
| Quanterix Corporation | -132.95 Million USD | 96.614% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -61.814% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 79.872% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 100.597% |
| TransMedics Group, Inc. | 121.13 Million USD | 103.716% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 82.805% |
| NeuroMetrix, Inc. | -1.49 Million USD | -201.908% |
| Hyperfine, Inc. | -75.61 Million USD | 94.047% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 102.958% |
| Biomerica, Inc. | -3.38 Million USD | -32.989% |
| Bone Biologics Corporation | -3.02 Million USD | -48.738% |
| AVITA Medical, Inc. | -26.23 Million USD | 82.839% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -144.867% |
| Silk Road Medical, Inc | 64.42 Million USD | 106.988% |